Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inulin Gel with Ipilimumab and Nivolumab in Advanced Renal Cell Carcinoma
NCT06866262Phase 2Recruiting
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Aug 2025
- Primary completion
- Aug 2031
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of inulin in renal cell carcinoma (RCC), sponsored by University of Michigan Rogel Cancer Center. Started Aug 2025; status: recruiting.
02
Drugs
inulin
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT06866262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06866262.